BridgeMD
New treatment option for Pre-Eclampsia
Official title Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia
ClinicalTrials.gov ID: NCT06539026
What this study is testing
- What it's testing
- The routine assessment of fluid status depends on clinical evaluation and invasive monitoring. The clinical assessment lacks objectivity and the invasive monitoring carries risks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- Critically ill pre-eclamptic patients for cesarean section
You likely can't join if
- Patient refusal
- severe cardiovascular disease ( ejection fraction \< 40 mmHg ), tricuspid regurge.
- contraindication for spinal anesthesia.
- failure to perform spinal anesthesia.
- severe hepatic.
- renal dysfunction
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.